AP2218A - Azithromycin dosage forms with reduced side effects - Google Patents
Azithromycin dosage forms with reduced side effectsInfo
- Publication number
- AP2218A AP2218A APAP/P/2004/003145A AP2004003145A AP2218A AP 2218 A AP2218 A AP 2218A AP 2004003145 A AP2004003145 A AP 2004003145A AP 2218 A AP2218 A AP 2218A
- Authority
- AP
- ARIPO
- Prior art keywords
- azithromycin
- alkalizing agent
- effective amount
- dosage form
- glyceryl
- Prior art date
Links
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 title abstract 13
- 229960004099 azithromycin Drugs 0.000 title abstract 13
- 230000000694 effects Effects 0.000 title abstract 3
- 239000002552 dosage form Substances 0.000 title 1
- 230000003113 alkalizing effect Effects 0.000 abstract 6
- 239000003795 chemical substances by application Substances 0.000 abstract 6
- 239000006186 oral dosage form Substances 0.000 abstract 5
- DMBUODUULYCPAK-UHFFFAOYSA-N 1,3-bis(docosanoyloxy)propan-2-yl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC DMBUODUULYCPAK-UHFFFAOYSA-N 0.000 abstract 4
- 241000124008 Mammalia Species 0.000 abstract 4
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 abstract 2
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 abstract 2
- 230000002496 gastric effect Effects 0.000 abstract 2
- 229940081618 glyceryl monobehenate Drugs 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229960000502 poloxamer Drugs 0.000 abstract 2
- 229920001983 poloxamer Polymers 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 229940100692 oral suspension Drugs 0.000 abstract 1
- 229940059096 powder for oral suspension Drugs 0.000 abstract 1
- 208000028172 protozoa infectious disease Diseases 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 239000003981 vehicle Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52708403P | 2003-12-04 | 2003-12-04 | |
| PCT/IB2004/001654 WO2005053650A1 (en) | 2003-12-04 | 2004-05-14 | Azithromycin dosage forms with reduced side effects |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AP2004003145A0 AP2004003145A0 (en) | 2004-09-30 |
| AP2218A true AP2218A (en) | 2011-04-20 |
Family
ID=34699855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| APAP/P/2004/003145A AP2218A (en) | 2003-12-04 | 2004-05-14 | Azithromycin dosage forms with reduced side effects |
Country Status (8)
| Country | Link |
|---|---|
| CN (1) | CN1697648B (es) |
| AP (1) | AP2218A (es) |
| AU (1) | AU2004216676B2 (es) |
| EC (1) | ECSP045351A (es) |
| GT (1) | GT200400183A (es) |
| TN (1) | TNSN05319A1 (es) |
| UA (1) | UA78793C2 (es) |
| ZA (1) | ZA200408075B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101340882B (zh) * | 2005-12-22 | 2015-02-11 | 大塚制药株式会社 | 含有药物的蜡基质粒子的制造方法、用于该方法的挤出机、及含有西洛他唑的缓释制剂 |
| CN103054813A (zh) * | 2012-12-31 | 2013-04-24 | 广东先强药业有限公司 | 阿奇霉素口服缓释干混悬剂及其制备方法 |
| CN104177457A (zh) * | 2013-05-23 | 2014-12-03 | 长春海悦药业有限公司 | 一种阿奇霉素药物原料及其制剂和用途 |
| WO2016145067A1 (en) * | 2015-03-10 | 2016-09-15 | Lumos Pharma, Inc. | Cyclocreatine microsuspension |
| JP7159174B2 (ja) * | 2017-02-02 | 2022-10-24 | マックマスター、ユニバーシティー | 抗菌剤用増強剤としての重炭酸塩 |
| CN114213484A (zh) * | 2021-12-21 | 2022-03-22 | 河北远征药业有限公司 | 一种泰地罗新1，2-丙二醇溶剂化合物及其制备方法 |
| CN115212173B (zh) * | 2022-07-11 | 2024-10-15 | 上海现代药物制剂工程研究中心有限公司 | 一种盐酸氨溴索球形缓释微粒、制备方法及用途 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0679400A1 (en) * | 1994-04-29 | 1995-11-02 | Pfizer Inc. | Oral dosage forms of azithromycin avoiding drugfood interaction |
| US5633006A (en) * | 1992-07-30 | 1997-05-27 | Pfizer Inc. | Taste-masking composition of bitter pharmaceutical agents |
| WO2003063838A1 (en) * | 2002-02-01 | 2003-08-07 | Pfizer Products Inc. | Dry granulated formulations of azithromycin |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1123279A (zh) * | 1995-06-15 | 1996-05-29 | 沈家祥 | 阿奇霉素水溶性盐、其注射剂型以及它们的用途 |
-
2004
- 2004-05-14 CN CN200480000209.2A patent/CN1697648B/zh not_active Expired - Lifetime
- 2004-05-14 AU AU2004216676A patent/AU2004216676B2/en not_active Expired
- 2004-05-14 UA UA20041210181A patent/UA78793C2/uk unknown
- 2004-05-14 AP APAP/P/2004/003145A patent/AP2218A/en active
- 2004-09-16 GT GT200400183A patent/GT200400183A/es unknown
- 2004-10-06 ZA ZA200408075A patent/ZA200408075B/en unknown
- 2004-10-08 EC ECSP045351 patent/ECSP045351A/es unknown
-
2005
- 2005-12-14 TN TNP2005000319A patent/TNSN05319A1/fr unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5633006A (en) * | 1992-07-30 | 1997-05-27 | Pfizer Inc. | Taste-masking composition of bitter pharmaceutical agents |
| EP0679400A1 (en) * | 1994-04-29 | 1995-11-02 | Pfizer Inc. | Oral dosage forms of azithromycin avoiding drugfood interaction |
| WO2003063838A1 (en) * | 2002-02-01 | 2003-08-07 | Pfizer Products Inc. | Dry granulated formulations of azithromycin |
Also Published As
| Publication number | Publication date |
|---|---|
| ECSP045351A (es) | 2005-01-28 |
| ZA200408075B (en) | 2007-01-31 |
| CN1697648B (zh) | 2010-06-23 |
| CN1697648A (zh) | 2005-11-16 |
| GT200400183A (es) | 2005-10-24 |
| AU2004216676A1 (en) | 2005-06-23 |
| UA78793C2 (en) | 2007-04-25 |
| TNSN05319A1 (fr) | 2007-07-10 |
| AP2004003145A0 (en) | 2004-09-30 |
| AU2004216676B2 (en) | 2011-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200518784A (en) | Azithromycin dosage forms with reduced side effects | |
| SG157406A1 (en) | Oral medicament for the modified release of at least one active principle, in multi-microcapsule form | |
| NZ524138A (en) | Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents | |
| WO2012079092A3 (en) | Testosterone undecanoate compositions | |
| WO2011160136A3 (en) | Progesterone containing oral dosage forms and related methods | |
| BE2011C013I2 (es) | ||
| EP1708685A4 (en) | GALENIC FORMS OF EFFERVESCENT ORAL OPIATES AND METHODS OF ADMINISTERING OPIATES | |
| RU2011152105A (ru) | Составы таблеток 3-цианохинолина и их применение | |
| NZ532063A (en) | Methods for wet granulating azithromycin | |
| WO2005055921A3 (en) | Compositions for treatment of ear disorders and methods of use thereof | |
| WO2007012019A3 (en) | Medicaments containing famotidine and ibuprofen and administration of same | |
| AP2003002763A0 (en) | Controlled release formulations for oral administration | |
| AP2218A (en) | Azithromycin dosage forms with reduced side effects | |
| NZ595798A (en) | Ectoparasiticidal methods and formulations | |
| TW200503785A (en) | Dosage form containing (S)-pantoprazole as active ingredient | |
| PL1648473T3 (pl) | Pojedyncza dawka szybko rozpuszczającej się azytromycyny | |
| MX2007010886A (es) | Metodos y formulaciones de acarbosa para tratar constipacion cronica. | |
| ES2179729B1 (es) | Forma farmaceutica solida de administracion oral dispersable en agua, que comprende rifampicina, isoniazida y piridoxina hidrocloruro, procedimiento para su obtencion y forma de presentacion de dicha forma farmaceutica. | |
| WO2003105811A8 (en) | PROGRESSIVE RELEASE COMPOSITIONS AND METHOD OF USE | |
| WO2011108882A3 (ko) | 유효성분으로서 레바미피드를 함유하는 골관절염 예방 또는 치료용 약학 조성물 | |
| SE0103613D0 (sv) | Novel formulation | |
| AP1820A (en) | Use of specific dose of fondaparinux sodium for the treatment of ACS. | |
| MD3121F1 (en) | Method of viral hepatitis B prophylaxis | |
| GB0224492D0 (en) | Pharmaceutical compositions of rapid drug delivery system to carry active ingredients for fast dissolving tablets by mouth administration | |
| TW200611686A (en) | Effervescent oral opiate dosage forms and methods of administering opiates |